Insecticides India Ltd Q3 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/m84xpbbqi5ozq0zwp3ptiud7.pdf

Key Takeaways


Price Cycle & Margin Recovery

Rajesh Aggarwal: "There is no guarantee that everything has bottomed out, but it looks that they are very much near the bottom because they are near all-time low. So, this is a good buying time."

Product Portfolio & Strategy

Rajesh Aggarwal: "The good part is that Focused Maharatna has grown over 50% in the previous year. So that was the reason we wanted to do that and very successfully, we are able to deliver that to the market because we need these products our engines and very well accepted across the country, I can say."

Manufacturing & Backward Integration


Distribution & Digital Initiatives


Market Environment & Demand

Rajesh Aggarwal: "But today, if you look at today's scenario, we can say that the price has bottomed, and the prices have stabilized at a level which is almost a very low level, and they are bound to bounce up from here."

Innovation & New Launches

Rajesh Aggarwal: "My vision is that I have to bring new solutions and I have to bring new IP protected solutions to the farmer, so that the retailer also enjoys, the dealer network also enjoys and the farmer or a consumer also gets the solution."

Guidance & Commitments

CommitmentSpecificsTimeline
Dahej plant fully operationalAll approvals received and plant runningThis quarter (Q4 FY24)
Sotanala plant startGround-breaking, then 18-month build programPlans near freezing; start imminent
Product rationalization completion75–80% of remaining tail products removedBy year-end
Maharatna contributionReach 65% of sales from MaharatnasNext year
Maharatna contributionReach 70% of sales from MaharatnasOver 2–3 years
Margin improvementDecent increase, visible step-by-stepFrom Q1 next fiscal
Isoxazole JV productApplication filedEnd of this year
Isoxazole JV productCommercial launch~2 years from filing
New kharif launchesHalf a dozen new brands across herbicide, insecticide, fungicideKharif season
Biological product launchesCertain biological products launchedShortly

Key Metrics

MetricQ3 FY24
Net revenue₹358 crore, marginally up from ₹356.5 crore in Q3 FY23
9M FY24 net revenue₹1,693.8 crore, up 13% YoY from ₹1,499.4 crore
EBITDA (excl. other income)₹26 crore, up 11.84% YoY from ₹23.26 crore
9M FY24 EBITDA₹153.59 crore, up 2.28% YoY from ₹150.16 crore
Profit after tax₹12.31 crore, up 31.41% YoY from ₹9.37 crore
9M FY24 profit after tax₹94.6 crore, up 2.26% YoY from ₹92.5 crore
Maharatna and Focused Maharatna revenue growth~14% YoY in the segment
Maharatna share of total net revenue (9M FY24)62%, up from 54% in 9M FY23
Focused Maharatna growth~15% (per management confirmation)
Average price impact10% to 12% decline, offset by decent double-digit volume growth
Insecticides category share52% of revenue, up from 45% in Q3 FY23
Herbicides category share35% of revenue, down from 43% in Q3 FY23
Fungicides category share9% of revenue, up from 8% in Q3 FY23
B2C segment share~78% of revenue, flat YoY
B2B segment share16% of revenue, down from 18% in Q3 FY23
Exports segment share6% of revenue, up from 4% in Q3 FY23
Distributor network~8,500 running distributors
Shinwa gross sales (cumulative)~₹150 crore, up from ~₹70 crore in the comparable prior-year period
Mission gross sales (half year)~₹80 crore
Biological segment annual gross sales~₹40 crore, stagnant
R&D spend (annual run-rate)₹12 crore to ₹15 crore